Cancer Screening Test Use — United States, 2015

  • White A
  • Thompson T
  • White M
  • et al.
393Citations
Citations of this article
230Readers
Mendeley users who have this article in their library.

Abstract

Regular breast, cervical, and colorectal cancer (CRC) screening with timely and appropriate follow-up and treatment reduces deaths from these cancers. Healthy People 2020 targets for cancer screening test use have been established, based on the most recent U.S. Preventive Services Task Force (USPSTF) guidelines. National Health Interview Survey (NHIS) data are used to monitor progress toward the targets. CDC used the 2013 NHIS, the most recent data available, to examine breast, cervical, and CRC screening use. Although some demographic subgroups attained targets, screening use overall was below the targets with no improvements from 2010 to 2013 in breast, cervical, or CRC screening use. Cervical cancer screening declined from 2010 to 2013. Increased efforts are needed to achieve targets and reduce screening disparities.

Cite

CITATION STYLE

APA

White, A., Thompson, T. D., White, M. C., Sabatino, S. A., de Moor, J., Doria-Rose, P. V., … Richardson, L. C. (2017). Cancer Screening Test Use — United States, 2015. MMWR. Morbidity and Mortality Weekly Report, 66(8), 201–206. https://doi.org/10.15585/mmwr.mm6608a1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free